RR

Rama Rao Kolla

Active Director Director DIN 10571599
DIN 10571599 First appointment Mar 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rama Rao Kolla

Data last updated:

Rama Rao Kolla is a Director at Medlivo Private Limited (since 2026) and Director at Aloden Technologies Private Limited (since 2024).

DIN 10571599
Primary Designation Director
First Appointment 30 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medlivo Private Limited U78100OD2026PTC052238
Director20 Jan 20262026Active
Aloden Technologies Private Limited U78300OD2024PTC045421
Director30 Mar 20242024Active

Board colleagues of Rama Rao Kolla

Directorship timeline

Open interactive timeline →
Medlivo Private Limited
Aloden Technologies Private Limited
Premium access

Shareholding and investment profile for Rama Rao Kolla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Rao Kolla

Rama Rao Kolla currently holds 2 directorships: Medlivo Private Limited (Director, since 20 Jan 2026); Aloden Technologies Private Limited (Director, since 30 Mar 2024).

Rama Rao Kolla was first appointed on 30 Mar 2024 as Director at Aloden Technologies Private Limited. The most recent appointment on record is 20 Jan 2026 at Medlivo Private Limited.

The current boards of Rama Rao Kolla's companies include Surendra Prasad Samal (Medlivo Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available